Patients with esophageal squamous cell carcinoma (ESCC) harboring high expression levels of TRPV2 had a worse five-year overall survival rate after surgery when compared to patients with low TRPV2 expression [45]. This evidence concerns the gene TRPV2 and esophageal squamous cell carcinoma.